JP2025505575A5 - - Google Patents
Info
- Publication number
- JP2025505575A5 JP2025505575A5 JP2024545922A JP2024545922A JP2025505575A5 JP 2025505575 A5 JP2025505575 A5 JP 2025505575A5 JP 2024545922 A JP2024545922 A JP 2024545922A JP 2024545922 A JP2024545922 A JP 2024545922A JP 2025505575 A5 JP2025505575 A5 JP 2025505575A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- viral vector
- administered
- corticosteroid
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306361P | 2022-02-03 | 2022-02-03 | |
| US63/306,361 | 2022-02-03 | ||
| US202263402850P | 2022-08-31 | 2022-08-31 | |
| US63/402,850 | 2022-08-31 | ||
| PCT/US2023/061951 WO2023150688A2 (en) | 2022-02-03 | 2023-02-03 | Compositions and methods for improved treatment of pompe disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505575A JP2025505575A (ja) | 2025-02-28 |
| JP2025505575A5 true JP2025505575A5 (https=) | 2026-02-12 |
Family
ID=87552969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545922A Pending JP2025505575A (ja) | 2022-02-03 | 2023-02-03 | ポンペ病の改善された治療のための組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250135038A1 (https=) |
| EP (1) | EP4472658A4 (https=) |
| JP (1) | JP2025505575A (https=) |
| KR (1) | KR20240145491A (https=) |
| AU (1) | AU2023216268A1 (https=) |
| CA (1) | CA3250992A1 (https=) |
| CL (1) | CL2024002307A1 (https=) |
| IL (1) | IL314586A (https=) |
| MX (1) | MX2024009519A (https=) |
| TW (1) | TW202342092A (https=) |
| WO (1) | WO2023150688A2 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003086452A2 (en) * | 2002-04-05 | 2003-10-23 | Genzyme Corporation | Methods of enhancing lysosomal storage disease therapy |
| JP2022554141A (ja) * | 2019-10-25 | 2022-12-28 | オーデンツ セラピューティクス，インコーポレーテッド | 糖原病を治療するための組成物及び方法 |
| KR20220098384A (ko) * | 2019-11-19 | 2022-07-12 | 아스클레피오스 바이오파마슈티컬, 인크. | 폼페병 및 리소좀 장애를 치료하기 위한 간-특이적 프로모터를 포함하는 치료적 아데노-관련 바이러스 |
| WO2021163451A1 (en) * | 2020-02-14 | 2021-08-19 | Asklepios Biopharmaceutical, Inc. | Method of treating gene therapy associated toxicity with antibiotics |
| WO2021202599A2 (en) * | 2020-04-01 | 2021-10-07 | Valiant Biosciences, Llc | Adeno-associated virus based compositions and related methods for inducing humoral immunity |
-
2023
- 2023-02-03 CA CA3250992A patent/CA3250992A1/en active Pending
- 2023-02-03 TW TW112103875A patent/TW202342092A/zh unknown
- 2023-02-03 EP EP23750442.8A patent/EP4472658A4/en active Pending
- 2023-02-03 AU AU2023216268A patent/AU2023216268A1/en active Pending
- 2023-02-03 WO PCT/US2023/061951 patent/WO2023150688A2/en not_active Ceased
- 2023-02-03 IL IL314586A patent/IL314586A/en unknown
- 2023-02-03 KR KR1020247029043A patent/KR20240145491A/ko active Pending
- 2023-02-03 JP JP2024545922A patent/JP2025505575A/ja active Pending
- 2023-02-03 MX MX2024009519A patent/MX2024009519A/es unknown
- 2023-02-03 US US18/835,480 patent/US20250135038A1/en active Pending
-
2024
- 2024-07-31 CL CL2024002307A patent/CL2024002307A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7588757B2 (en) | Methods of treating Parkinson's disease using recombinant adeno-associated virus virions | |
| GB2590880A (en) | RNA and DNA base editing via engineered ADAR recruitment | |
| CN102227500A (zh) | 胆色素原脱氨酶基因治疗 | |
| AU2023202598B2 (en) | Intrathecal delivery of recombinant Adeno-associated virus encoding Methyl-CpG binding protein 2 | |
| Bellotti et al. | Molecular approaches for the treatment of Pompe disease | |
| TW201629225A (zh) | 第九因子基因療法 | |
| JP2022531809A (ja) | ＡＴＰａｓｅ媒介性疾患の処置のための組成物および方法 | |
| JP2022520232A (ja) | ダノン病の治療のための遺伝子療法ベクター | |
| JP2023524010A5 (https=) | ||
| JP2022527597A (ja) | 筋肉発現のためのハイブリッドプロモーター | |
| JP2022554141A5 (https=) | ||
| JP2025505575A5 (https=) | ||
| JP2024520411A5 (https=) | ||
| AU2021207468A1 (en) | Methods of treating phenylketonuria | |
| RU2024125625A (ru) | Композиции и способы для оптимизированного лечения болезни помпе | |
| WO2024020574A2 (en) | Auf1 gene therapy for limb girdle muscular dystrophy | |
| US20240409955A1 (en) | Auf1 combination therapies for treatment of muscle degenerative disease | |
| JP2024534415A5 (https=) | ||
| US20220136005A1 (en) | One-step gene therapy for duchenne muscular dystrophy via gene replacement and anti-inflammation | |
| RU2023134651A (ru) | Композиции и способы улучшенного лечения х-сцепленной миотубулярной миопатии | |
| US20250161483A1 (en) | Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxia | |
| JP2024510972A5 (https=) | ||
| CN120603602A (zh) | 使用aav载体的斑菲素蛋白-2(pkp2)基因治疗 | |
| JP2026012759A (ja) | 筋ジストロフィーを治療するための方法および組成物 | |
| HK40119830A (zh) | 用於治疗和预防与弗里德赖希共济失调相关的心肌病的方法和药物组合物 |